GGrantIndex
← Leaderboards

Donald Bellgrau

University Of Colorado Denver

$4,610,601
Attributed
$4,610,601
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $357.6K · FY200616
$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16

Funding mix

By agency

NIH$4,610,601 · 6

By mechanism

P30$2,554,768 · 3
R01$1,291,052 · 1
R43$764,781 · 2

Top collaborators

No co-investigators on record.

Most similar at University Of Colorado Denver

Same institution · by research overlap

Others in their field

Top investigators on “Programs

Research focus

ProgramsMalignant NeoplasmsUniversitiesComprehensive Cancer CenterInterestResource SharingCancer CenterColoradoCancer Center Support GrantFlow CytometryTranslatingRecruitment ActivityApoptosisImmune SystemImmunotherapyImmunotherapeutic AgentInflammationAnimal TissueAffectCollaborationsBiomedical FacilityDiabetes MellitusImmunologicsCellular Biology

Grant awards (28)

IMMUNOLOGY-IMMUNOTHERAPY$254,052
P30 · FY2016 · CA · contact PI
IMMUNOLOGY-IMMUNOTHERAPY$255,589
P30 · FY2015 · CA · contact PI
IMMUNOLOGY-IMMUNOTHERAPY$249,641
P30 · FY2014 · CA · contact PI
IMMUNOLOGY-IMMUNOTHERAPY$183,776
P30 · FY2013 · CA · contact PI
IMMUNOLOGY-IMMUNOTHERAPY$963
P30 · FY2013 · CA · contact PI
IMMUNOLOGY-IMMUNOTHERAPY$254,604
P30 · FY2012 · CA · contact PI
IMMUNOLOGY-IMMUNOTHERAPY$23,024
P30 · FY2010 · CA · contact PI
IMMUNOLOGY-IMMUNOTHERAPY$24,358
P30 · FY2009 · CA · contact PI
IMMUNOLOGY-IMMUNOTHERAPY$22,910
P30 · FY2008 · CA · contact PI
Provoking anti-tumor immune responses with Fas ligand$335,358
R43 · FY2007 · CA · contact PI
IMMUNOLOGY-IMMUNOTHERAPY$22,280
P30 · FY2007 · CA · contact PI
Provoking anti-tumor immune responses with Fas ligand$329,413
R43 · FY2006 · CA · contact PI
IMMUNOLOGY-IMMUNOTHERAPY$12,359
P30 · FY2006 · CA · contact PI
A NOVEL T CELL ACTIVATION CONTROLLED BY A DISEASE GENE$322,763
R01 · FY2004 · DK
A NOVEL T CELL ACTIVATION CONTROLLED BY A DISEASE GENE$322,763
R01 · FY2003 · DK
A NOVEL T CELL ACTIVATION CONTROLLED BY A DISEASE GENE$322,763
R01 · FY2002 · DK
IMMUNOLOGY AND IMMUNOTHERAPY$250,404
P30 · FY2002 · CA
IMMUNOLOGY AND IMMUNOTHERAPY$250,404
P30 · FY2002 · CA
CORE--CYTOMETRY FACILITY$0
P30 · FY2002 · DK
CORE--CYTOMETRY FACILITY$0
P30 · FY2002 · DK
A NOVEL T CELL ACTIVATION CONTROLLED BY A DISEASE GENE$322,763
R01 · FY2001 · DK
IMMUNOLOGY AND IMMUNOTHERAPY$250,404
P30 · FY2001 · CA
CORE--CYTOMETRY FACILITY$250,000
P30 · FY2001 · DK
USE OF FAS LIGAND TO SUPPRESS ARTHRITIS$100,010
R43 · FY2001 · AI
IMMUNOLOGY AND IMMUNOTHERAPY$0
P30 · FY2001 · CA
CORE--CYTOMETRY FACILITY$0
P30 · FY2001 · DK
CORE--CYTOMETRY FACILITY$0
P30 · FY2001 · DK
CORE--CYTOMETRY FACILITY$250,000
P30 · FY2000 · DK